table of content
1 Introduction to Research & Analysis Reports
1.1 GABA Receptor Agonist Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global GABA Receptor Agonist Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global GABA Receptor Agonist Drug Overall Market Size
2.1 Global GABA Receptor Agonist Drug Market Size: 2021 VS 2028
2.2 Global GABA Receptor Agonist Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global GABA Receptor Agonist Drug Sales: 2017-2028
3 Company Landscape
3.1 Top GABA Receptor Agonist Drug Players in Global Market
3.2 Top Global GABA Receptor Agonist Drug Companies Ranked by Revenue
3.3 Global GABA Receptor Agonist Drug Revenue by Companies
3.4 Global GABA Receptor Agonist Drug Sales by Companies
3.5 Global GABA Receptor Agonist Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 GABA Receptor Agonist Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers GABA Receptor Agonist Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 GABA Receptor Agonist Drug Players in Global Market
3.8.1 List of Global Tier 1 GABA Receptor Agonist Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 GABA Receptor Agonist Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global GABA Receptor Agonist Drug Market Size Markets, 2021 & 2028
4.1.2 Bamaluzole
4.1.3 Phenibut
4.1.4 Baclofen
4.1.5 Gaboxadol
4.1.6 Klonopin (clonazepam)
4.1.7 Tiagbine
4.2 By Type - Global GABA Receptor Agonist Drug Revenue & Forecasts
4.2.1 By Type - Global GABA Receptor Agonist Drug Revenue, 2017-2022
4.2.2 By Type - Global GABA Receptor Agonist Drug Revenue, 2023-2028
4.2.3 By Type - Global GABA Receptor Agonist Drug Revenue Market Share, 2017-2028
4.3 By Type - Global GABA Receptor Agonist Drug Sales & Forecasts
4.3.1 By Type - Global GABA Receptor Agonist Drug Sales, 2017-2022
4.3.2 By Type - Global GABA Receptor Agonist Drug Sales, 2023-2028
4.3.3 By Type - Global GABA Receptor Agonist Drug Sales Market Share, 2017-2028
4.4 By Type - Global GABA Receptor Agonist Drug Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global GABA Receptor Agonist Drug Market Size, 2021 & 2028
5.1.2 Attention Deficit Hyperactivity Disorder (ADHD)
5.1.3 Psychiatric Disorders and Depression
5.1.4 Alzheimer
5.1.5 Epilepsy and Seizure
5.1.6 Anxiety and Sleep Disorders
5.1.7 Obesity and Alcoholism
5.2 By Application - Global GABA Receptor Agonist Drug Revenue & Forecasts
5.2.1 By Application - Global GABA Receptor Agonist Drug Revenue, 2017-2022
5.2.2 By Application - Global GABA Receptor Agonist Drug Revenue, 2023-2028
5.2.3 By Application - Global GABA Receptor Agonist Drug Revenue Market Share, 2017-2028
5.3 By Application - Global GABA Receptor Agonist Drug Sales & Forecasts
5.3.1 By Application - Global GABA Receptor Agonist Drug Sales, 2017-2022
5.3.2 By Application - Global GABA Receptor Agonist Drug Sales, 2023-2028
5.3.3 By Application - Global GABA Receptor Agonist Drug Sales Market Share, 2017-2028
5.4 By Application - Global GABA Receptor Agonist Drug Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global GABA Receptor Agonist Drug Market Size, 2021 & 2028
6.2 By Region - Global GABA Receptor Agonist Drug Revenue & Forecasts
6.2.1 By Region - Global GABA Receptor Agonist Drug Revenue, 2017-2022
6.2.2 By Region - Global GABA Receptor Agonist Drug Revenue, 2023-2028
6.2.3 By Region - Global GABA Receptor Agonist Drug Revenue Market Share, 2017-2028
6.3 By Region - Global GABA Receptor Agonist Drug Sales & Forecasts
6.3.1 By Region - Global GABA Receptor Agonist Drug Sales, 2017-2022
6.3.2 By Region - Global GABA Receptor Agonist Drug Sales, 2023-2028
6.3.3 By Region - Global GABA Receptor Agonist Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America GABA Receptor Agonist Drug Revenue, 2017-2028
6.4.2 By Country - North America GABA Receptor Agonist Drug Sales, 2017-2028
6.4.3 US GABA Receptor Agonist Drug Market Size, 2017-2028
6.4.4 Canada GABA Receptor Agonist Drug Market Size, 2017-2028
6.4.5 Mexico GABA Receptor Agonist Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe GABA Receptor Agonist Drug Revenue, 2017-2028
6.5.2 By Country - Europe GABA Receptor Agonist Drug Sales, 2017-2028
6.5.3 Germany GABA Receptor Agonist Drug Market Size, 2017-2028
6.5.4 France GABA Receptor Agonist Drug Market Size, 2017-2028
6.5.5 U.K. GABA Receptor Agonist Drug Market Size, 2017-2028
6.5.6 Italy GABA Receptor Agonist Drug Market Size, 2017-2028
6.5.7 Russia GABA Receptor Agonist Drug Market Size, 2017-2028
6.5.8 Nordic Countries GABA Receptor Agonist Drug Market Size, 2017-2028
6.5.9 Benelux GABA Receptor Agonist Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia GABA Receptor Agonist Drug Revenue, 2017-2028
6.6.2 By Region - Asia GABA Receptor Agonist Drug Sales, 2017-2028
6.6.3 China GABA Receptor Agonist Drug Market Size, 2017-2028
6.6.4 Japan GABA Receptor Agonist Drug Market Size, 2017-2028
6.6.5 South Korea GABA Receptor Agonist Drug Market Size, 2017-2028
6.6.6 Southeast Asia GABA Receptor Agonist Drug Market Size, 2017-2028
6.6.7 India GABA Receptor Agonist Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America GABA Receptor Agonist Drug Revenue, 2017-2028
6.7.2 By Country - South America GABA Receptor Agonist Drug Sales, 2017-2028
6.7.3 Brazil GABA Receptor Agonist Drug Market Size, 2017-2028
6.7.4 Argentina GABA Receptor Agonist Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa GABA Receptor Agonist Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa GABA Receptor Agonist Drug Sales, 2017-2028
6.8.3 Turkey GABA Receptor Agonist Drug Market Size, 2017-2028
6.8.4 Israel GABA Receptor Agonist Drug Market Size, 2017-2028
6.8.5 Saudi Arabia GABA Receptor Agonist Drug Market Size, 2017-2028
6.8.6 UAE GABA Receptor Agonist Drug Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Advicenne
7.1.1 Advicenne Corporate Summary
7.1.2 Advicenne Business Overview
7.1.3 Advicenne GABA Receptor Agonist Drug Major Product Offerings
7.1.4 Advicenne GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.1.5 Advicenne Key News
7.2 AstraZeneca
7.2.1 AstraZeneca Corporate Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca GABA Receptor Agonist Drug Major Product Offerings
7.2.4 AstraZeneca GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.2.5 AstraZeneca Key News
7.3 Athena Drug Delivery Solutions
7.3.1 Athena Drug Delivery Solutions Corporate Summary
7.3.2 Athena Drug Delivery Solutions Business Overview
7.3.3 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Major Product Offerings
7.3.4 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.3.5 Athena Drug Delivery Solutions Key News
7.4 Biocodex
7.4.1 Biocodex Corporate Summary
7.4.2 Biocodex Business Overview
7.4.3 Biocodex GABA Receptor Agonist Drug Major Product Offerings
7.4.4 Biocodex GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.4.5 Biocodex Key News
7.5 Elan Corporation
7.5.1 Elan Corporation Corporate Summary
7.5.2 Elan Corporation Business Overview
7.5.3 Elan Corporation GABA Receptor Agonist Drug Major Product Offerings
7.5.4 Elan Corporation GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.5.5 Elan Corporation Key News
7.6 Eli Lilly and Company
7.6.1 Eli Lilly and Company Corporate Summary
7.6.2 Eli Lilly and Company Business Overview
7.6.3 Eli Lilly and Company GABA Receptor Agonist Drug Major Product Offerings
7.6.4 Eli Lilly and Company GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.6.5 Eli Lilly and Company Key News
7.7 H.LundBeck, Merck and Co
7.7.1 H.LundBeck, Merck and Co Corporate Summary
7.7.2 H.LundBeck, Merck and Co Business Overview
7.7.3 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Major Product Offerings
7.7.4 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.7.5 H.LundBeck, Merck and Co Key News
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Corporate Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline GABA Receptor Agonist Drug Major Product Offerings
7.8.4 GlaxoSmithKline GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.8.5 GlaxoSmithKline Key News
7.9 NovaDel Pharma
7.9.1 NovaDel Pharma Corporate Summary
7.9.2 NovaDel Pharma Business Overview
7.9.3 NovaDel Pharma GABA Receptor Agonist Drug Major Product Offerings
7.9.4 NovaDel Pharma GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.9.5 NovaDel Pharma Key News
7.10 Novartis
7.10.1 Novartis Corporate Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis GABA Receptor Agonist Drug Major Product Offerings
7.10.4 Novartis GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.10.5 Novartis Key News
7.11 OVATION Pharmaceuticals
7.11.1 OVATION Pharmaceuticals Corporate Summary
7.11.2 OVATION Pharmaceuticals GABA Receptor Agonist Drug Business Overview
7.11.3 OVATION Pharmaceuticals GABA Receptor Agonist Drug Major Product Offerings
7.11.4 OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.11.5 OVATION Pharmaceuticals Key News
7.12 Osmotica Pharmaceutical
7.12.1 Osmotica Pharmaceutical Corporate Summary
7.12.2 Osmotica Pharmaceutical GABA Receptor Agonist Drug Business Overview
7.12.3 Osmotica Pharmaceutical GABA Receptor Agonist Drug Major Product Offerings
7.12.4 Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.12.5 Osmotica Pharmaceutical Key News
7.13 Pfizer
7.13.1 Pfizer Corporate Summary
7.13.2 Pfizer GABA Receptor Agonist Drug Business Overview
7.13.3 Pfizer GABA Receptor Agonist Drug Major Product Offerings
7.13.4 Pfizer GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.13.5 Pfizer Key News
7.14 sanofi-aventis
7.14.1 sanofi-aventis Corporate Summary
7.14.2 sanofi-aventis Business Overview
7.14.3 sanofi-aventis GABA Receptor Agonist Drug Major Product Offerings
7.14.4 sanofi-aventis GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.14.5 sanofi-aventis Key News
7.15 VIVUS
7.15.1 VIVUS Corporate Summary
7.15.2 VIVUS Business Overview
7.15.3 VIVUS GABA Receptor Agonist Drug Major Product Offerings
7.15.4 VIVUS GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.15.5 VIVUS Key News
7.16 XenoPort
7.16.1 XenoPort Corporate Summary
7.16.2 XenoPort Business Overview
7.16.3 XenoPort GABA Receptor Agonist Drug Major Product Offerings
7.16.4 XenoPort GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.16.5 XenoPort Key News
8 Global GABA Receptor Agonist Drug Production Capacity, Analysis
8.1 Global GABA Receptor Agonist Drug Production Capacity, 2017-2028
8.2 GABA Receptor Agonist Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global GABA Receptor Agonist Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 GABA Receptor Agonist Drug Supply Chain Analysis
10.1 GABA Receptor Agonist Drug Industry Value Chain
10.2 GABA Receptor Agonist Drug Upstream Market
10.3 GABA Receptor Agonist Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 GABA Receptor Agonist Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
